Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Pluristem
Pluristem
Pluristem says FDA puts muscle pain drug study on clinical hold
Reuters
Tue, 06/4/13 - 12:01 pm
Pluristem
FDA
IND 15038
stem cells
intermittent claudication
Pluristem launches Phase I clinical trial to treat tendonitis with stem cells
Mass Device
Fri, 05/17/13 - 11:56 am
tendonitis
stem cells
Pluristem
PLX-PAD
The Vatican / NeoStem Partnership Looks To Create Interest And Advance Cell Therapy
Seeking Alpha
Wed, 04/10/13 - 11:17 am
NeoStem
stem cells
Baxter International
StemCells
Pluristem
Osiris
Neuralstem
Pluristem Gets FDA's Orphan Drug Nod for Anemia Treatment
Motley Fool
Fri, 02/22/13 - 11:08 am
orphan drugs
Pluristem
FDA
placental expanded cells
Pluristem Standardizes Stem Cell Therapy, Opening Door To The Future Of Medicine
Seeking Alpha
Mon, 11/5/12 - 12:49 pm
Pluristem
stem cells
Mesoblast
Osiris
Thermo Fisher
Here are 5 Biopharmaceutical Companies on the Rise
Wall St Cheat Street
Sat, 10/13/12 - 11:55 am
Pluristem
Ariad Pharmaceuticals
Sarepta Therapeutics
Amicus Therapeutics
StemCells
The Promising, Cheap, And Growing Cell Therapy Arena Continues To Outperform The Market
Seeking Alpha
Mon, 09/24/12 - 11:17 am
Neuralstem
NeoStem
Osiris
Pluristem
stem cells
StemCells
Pluristem prices public offering of 8 mln units at $4/shr
Reuters
Thu, 09/13/12 - 10:43 am
stock offering
Pluristem
Pluristem to Begin IC Phase II Trial
Yahoo/Zacks
Sat, 08/25/12 - 11:34 am
Pluristem
intermittent claudication
placental expanded cells
Stem Cell Therapy Outlook Starting To Match Clinical Results
Seeking Alpha
Tue, 08/21/12 - 11:38 am
Aastrom Biosciences
Baxter International
NeoStem
Osiris
Pluristem
AMR-101
Pluristem's Cell Therapy For Bone Marrow A Blockbuster In The Making
Seeking Alpha
Wed, 08/8/12 - 12:04 pm
Pluristem
Amgen
AstraZeneca
Celgene
Dendreon
Eli Lilly
Medivation
Merck
Onyx
Pfizer
bone marrow disorder
Are Stem Cells Becoming The Next Bull Market In The Biotech Space?
Seeking Alpha
Tue, 07/31/12 - 11:09 am
stem cells
Bristol-Myers Squibb
Pluristem
StemCells
NeoStem
Osiris
Pluristem, NIH to study stem cells to treat radiation syndrome
Reuters
Thu, 07/26/12 - 09:30 am
Pluristem
NIH
stem cells
radiation syndrome
Pluristem Pioneering Intramuscular Placenta-Based Cell Therapies
Seeking Alpha
Tue, 07/3/12 - 11:44 am
Pluristem
10 Biotech Stocks Positively Correlated To Volatility
Seeking Alpha
Thu, 03/22/12 - 11:35 am
Amyris
Aveo
China Biologic
Chelsea Therapeutics
Pluristem
Spectrum Pharmaceuticals
Questcor
Theravance
Vical
Zalicus
Pluristem Vs. Geron: An Insider's View Of The Stem Cell Story
Seeking Alpha
Mon, 12/19/11 - 08:26 am
stem cells
Pluristem
Geron
FACTBOX-Stem cell advances focus on heart, inflammation
Reuters
Mon, 12/5/11 - 12:25 pm
stem cells
inflammation
Aastrom
Arthersys
Baxter
Celgene
Cytori
Mesoblast
Fibrocell Science
StemCells
Pluristem
Osiris
Pharmicell
NeoStem
Neuralstem
Gamida Cell
Encouraging Pipelines From Pluristem and Fibrocell Science Gain Attention
Yahoo/MarketWire
Sat, 08/27/11 - 12:54 pm
Pluristem
Fibrocell Science
United Therapeutics licenses Pluristem lung disease treatment in deal that could top $55M
Yahoo/AP
Mon, 06/20/11 - 09:26 am
United Therapeutics
Pluristem
PAH
Competition Between Aastrom Bio and Pluristem Heating Up
Seeking Alpha
Mon, 04/18/11 - 04:54 pm
Aastrom
Pluristem
peripheral arterial disease
Sanofi
Pages
« first
‹ previous
1
2
3
next ›
last »